Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NOTA-RM26 PET/CT in Prostate Cancer
NCT03164837Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2016
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68Ga-NOTA-RM26 in prostate cancer (PCa), sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized uptake value at 1 year. Status: unknown.
02
Drugs
68Ga-NOTA-RM26
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03164837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03164837.